Multi-OMICs orchestration enabled by artificial intelligence in inflammatory bowel disease: An exciting future.
作者信息
Iacucci Marietta, Santacroce Giovanni
机构信息
APC Microbiome Ireland, College of Medicine and Health, University College Cork (UCC), Cork, Ireland.
出版信息
United European Gastroenterol J. 2024 Dec;12(10):1350-1351. doi: 10.1002/ueg2.12663. Epub 2024 Nov 7.
Abstract
摘要
相似文献
1
Multi-OMICs orchestration enabled by artificial intelligence in inflammatory bowel disease: An exciting future.人工智能助力炎症性肠病中的多组学协调：激动人心的未来。
United European Gastroenterol J. 2024 Dec;12(10):1350-1351. doi: 10.1002/ueg2.12663. Epub 2024 Nov 7.
2
Artificial intelligence-based multi-omics analysis fuels cancer precision medicine.基于人工智能的多组学分析推动癌症精准医学发展。
Semin Cancer Biol. 2023 Jan;88:187-200. doi: 10.1016/j.semcancer.2022.12.009. Epub 2022 Dec 31.
3
Artificial intelligence and endo-histo-omics: new dimensions of precision endoscopy and histology in inflammatory bowel disease.人工智能与内组织组学：炎症性肠病精准内镜和组织学的新维度。
Lancet Gastroenterol Hepatol. 2024 Aug;9(8):758-772. doi: 10.1016/S2468-1253(24)00053-0. Epub 2024 May 14.
4
Precision medicine in colorectal cancer: Leveraging multi-omics, spatial omics, and artificial intelligence.结直肠癌的精准医学：利用多组学、空间组学和人工智能
Clin Chim Acta. 2024 Jun 1;559:119686. doi: 10.1016/j.cca.2024.119686. Epub 2024 Apr 23.
5
Omics big data and medical artificial intelligence.组学大数据与医疗人工智能。
Yi Chuan. 2021 Oct 20;43(10):930-937. doi: 10.16288/j.yczz.21-215.
6
Impact of artificial intelligence on prognosis, shared decision-making, and precision medicine for patients with inflammatory bowel disease: a perspective and expert opinion.人工智能对炎症性肠病患者预后、共同决策和精准医学的影响：观点和专家意见。
Ann Med. 2023;55(2):2300670. doi: 10.1080/07853890.2023.2300670. Epub 2024 Jan 1.
7
Omics and Multi-Omics in IBD: No Integration, No Breakthroughs.炎症性肠病中的组学和多组学：没有整合，就没有突破。
Int J Mol Sci. 2023 Oct 5;24(19):14912. doi: 10.3390/ijms241914912.
8
Inflammatory bowel disease genomics, transcriptomics, proteomics and metagenomics meet artificial intelligence.炎症性肠病基因组学、转录组学、蛋白质组学和宏基因组学与人工智能相遇。
United European Gastroenterol J. 2024 Dec;12(10):1461-1480. doi: 10.1002/ueg2.12655. Epub 2024 Aug 31.
9
Artificial intelligence in inflammatory bowel disease endoscopy: current landscape and the road ahead.炎症性肠病内镜检查中的人工智能：现状与未来之路。
Ther Adv Gastrointest Endosc. 2021 Jul 14;14:26317745211017809. doi: 10.1177/26317745211017809. eCollection 2021 Jan-Dec.
10
Artificial Intelligence-Driven Personalized Medicine: Transforming Clinical Practice in Inflammatory Bowel Disease.人工智能驱动的个性化医疗：改变炎症性肠病的临床实践
Gastroenterology. 2025 Mar 10. doi: 10.1053/j.gastro.2025.03.005.
引用本文的文献
1
Endo-Histo foundational fusion model: a novel artificial intelligence for assessing histologic remission and response to therapy in ulcerative colitis clinical trial.内镜-组织学基础融合模型：一种用于评估溃疡性结肠炎临床试验中组织学缓解及治疗反应的新型人工智能技术。
J Crohns Colitis. 2025 Jul 3;19(7). doi: 10.1093/ecco-jcc/jjaf108.
2
Factors driving persistence to first-line advanced therapies in inflammatory bowel disease: a real-world study from a tertiary referral centre.炎症性肠病患者坚持一线晚期治疗的驱动因素：来自三级转诊中心的真实世界研究
Intern Emerg Med. 2025 Apr 25. doi: 10.1007/s11739-025-03943-1.
本文引用的文献
1
Inflammatory bowel disease genomics, transcriptomics, proteomics and metagenomics meet artificial intelligence.炎症性肠病基因组学、转录组学、蛋白质组学和宏基因组学与人工智能相遇。
United European Gastroenterol J. 2024 Dec;12(10):1461-1480. doi: 10.1002/ueg2.12655. Epub 2024 Aug 31.
2
Artificial intelligence and endo-histo-omics: new dimensions of precision endoscopy and histology in inflammatory bowel disease.人工智能与内组织组学：炎症性肠病精准内镜和组织学的新维度。
Lancet Gastroenterol Hepatol. 2024 Aug;9(8):758-772. doi: 10.1016/S2468-1253(24)00053-0. Epub 2024 May 14.
3
Defining predictors of responsiveness to advanced therapies in Crohn's disease and ulcerative colitis: protocol for the IBD-RESPONSE and nested CD-metaRESPONSE prospective, multicentre, observational cohort study in precision medicine.定义克罗恩病和溃疡性结肠炎对先进治疗方法反应的预测因素：精准医学中 IBD-RESPONSE 和嵌套 CD-metaRESPONSE 前瞻性、多中心、观察性队列研究的方案。
BMJ Open. 2024 Apr 17;14(4):e073639. doi: 10.1136/bmjopen-2023-073639.
4
Mucosal host-microbe interactions associate with clinical phenotypes in inflammatory bowel disease.黏膜宿主-微生物相互作用与炎症性肠病的临床表型相关。
Nat Commun. 2024 Feb 17;15(1):1470. doi: 10.1038/s41467-024-45855-2.
5
High-throughput omics technologies in inflammatory bowel disease.炎症性肠病中的高通量组学技术
Clin Chim Acta. 2024 Mar 1;555:117828. doi: 10.1016/j.cca.2024.117828. Epub 2024 Feb 13.
6
IBD Systems Biology Is Here to Stay.IBD 系统生物学应运而生。
Inflamm Bowel Dis. 2021 May 17;27(6):760-770. doi: 10.1093/ibd/izaa343.
7
Positioning Therapies in Ulcerative Colitis.溃疡性结肠炎的定位疗法
Clin Gastroenterol Hepatol. 2020 May;18(6):1280-1290.e1. doi: 10.1016/j.cgh.2020.01.017. Epub 2020 Jan 23.
8
Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases.炎症性肠病中的肠道微生物生态系统的多组学研究。
Nature. 2019 May;569(7758):655-662. doi: 10.1038/s41586-019-1237-9. Epub 2019 May 29.
9
DNA Methylation and Transcription Patterns in Intestinal Epithelial Cells From Pediatric Patients With Inflammatory Bowel Diseases Differentiate Disease Subtypes and Associate With Outcome.肠上皮细胞中 DNA 甲基化和转录模式在儿童炎症性肠病患者中区分疾病亚型并与结局相关。
Gastroenterology. 2018 Feb;154(3):585-598. doi: 10.1053/j.gastro.2017.10.007. Epub 2017 Oct 12.
Zotero 插件